Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Ono's new MMP inhibitors

March 18, 1998

Enbrel safety established in juvenile RA patients; efficacy data now being generated

March 17, 1998

Glaxo Wellcome researches MMP inhibitors

March 17, 1998

Inhibitors of selectin binding and cell adhesion prepared at Nippon Shinyaku

March 17, 1998

Favorable results obtained with Enbrel combination in RA

March 16, 1998

Procter & Gamble reports novel NSAIDs with improved GI safety

March 16, 1998

Celgene expands phase I trial of TNF-alpha inhibitor

March 16, 1998

A new hypothesis may explain the high incidence of autoimmune disorders in women

March 13, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Biomatrix and Novartis sign distribution agreement for Synvisc

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...